$TCRX
TScan Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is TCRX up today? It is at $0.779 (+0.43%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TCRX spikes, and full due diligence on TCRX — key stats, earnings, dilution and insider activity. Free.
Get free $TCRX alerts the moment volume spikes
Our scanner flagged $TCRX 1 time in the last 30 days. Create a free account to track $TCRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.779
- Change today
- +0.43%
- Previous close
- $0.776
- 52-week range
- $0.716 – $2.57
- Market cap
- $53M
- Institutional own.
- 60.98%
- Total held
- 66.5%
- Tradeable float
- 22.7M 34% of shares · after 5% insiders + 61% institutions
- Short interest
- 1.6M ▲ +13% vs prior · as of 2026-07-31
- Short % of float
- 6.9%
- Days to cover
- 2.8d
- Avg daily volume
- 684K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.5x
- 15m
- 0.2x
- 1h
- 0.5x
- 1D
- --
Get free TCRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $TCRX moving today?
Here is the latest on TCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAgreement Terminated, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
10 open-market buys0 buys, 0 sells last 3 months (3/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +6K | added <0.1% | 8.02M | $6K at $0.900 | Dec 23, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +76K 0.1% of company | added 1.0% | 8.01M | $68K at $0.900 | Dec 22, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +80K 0.1% of company | added 1.0% | 7.94M | $72K at $0.900 | Dec 19, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +1.20M 1.8% of company | added 18% | 7.95M | $1.4M at $1.20 | May 20, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +1.39M 2.0% of company | added 26% | 6.75M | $1.7M at $1.20 | May 19, 25 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +100K 0.1% of company | added 1.9% | 5.36M | $290K at $2.90 | Dec 13, 24 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +32K 0.05% of company | added 0.6% | 5.26M | $96K at $3.01 | Dec 12, 24 |
Lynx1 Capital Management Lp Beneficial Owner (10%) | Bought (open market) | +947 | added <0.1% | 5.23M | $4K at $4.34 | Nov 15, 24 |
Klencke Barbara Director | Bought (open market) | +5K | added 13% | 45K | $26K at $5.29 | Sep 23, 24 |
Klencke Barbara Director | Bought (open market) | +5K | added 14% | 40K | $28K at $5.53 | Aug 26, 24 |
Zdraveski Zoran Officer | Sold (automatic/other) | -165K 0.2% of company | sold 97% | 5K | $952K at $5.78 | Aug 23, 24 |
Zdraveski Zoran Officer | Other | 157K 0.2% of company | added 100% | 169K | $285K at $1.81 | Aug 23, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$TCRX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$TCRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to TCRX
Comparable names in biological products, (no diagnostic substances), closest in size first.
TCRX stock FAQ
Why is $TCRX moving today?
Here is the latest on TCRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TCRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the TCRX stock price today?
TCRX last traded at $0.779, up 0.43% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live TCRX alerts?
The TCRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TCRX 1 time in the last 30 days.
What exchange is TCRX on?
TCRX (TScan Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $53M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is TCRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TCRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.